Biolase Inc (BIOL) - Medical Equipment - Deals and Alliances Profile
October 2018
66
About the Report
About the Report
Summary
Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diode systems. Its laser systems find applications in minimally invasive dental procedures, such as cosmetic, restorative and complex surgical applications. Biolase offers these products to dentists, periodontists, endodontists, oral surgeons and other dental specialists. It also offers consumables products, other imaging system products and maintenance service. The company distributes its products through direct sales force, agents and distributors. It has operations in the Americas, Europe, the Middle East and Asia-Pacific. Biolase is headquartered in California, the US.
Biolase Inc (BIOL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Biolase Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biolase Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biolase Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Biolase Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Biolase Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
BIOLASE Technology Acquires 180 Waterlase MD Turbo Laser Systems From Henry Schein 12
Partnerships 13
Biolase Enters Into Licensing Agreement With Valem 13
Biolase Enters into Research Agreement with McGuire Institute 14
Biolase Enters into Agreement with IPG Photonics 15
Biolase Enters Into Distribution Agreement With Stratasys 16
Biolase To Enter Into Co-Development Agreement With Auris Surgical Robotics 17
Biolase Enters Into Co-Marketing Agreement With Sun Dental Labs For TRIOS 18
Biolase Enters Into Distribution Agreement With 3Shape For TRIOS 19
BIOLASE Enters Into Co-Marketing Agreement With Cefla Dental 20
Equity Offering 21
Biolase Plans to Raise Funds through Public Offering of Shares 21
Biolase Raises USD12 Million in Rights offering of Shares 22
Biolase Plans to Raise up to USD10 Million in Public Offering of Shares 23
Biolase Raises USD10 Million in Private Placement of Series D Preferred Stock 24
Biolase Raises USD10 Million in Private Placement of Preferred Stock 26
Biolase Raises USD35 Million in Private Placement of Shares 28
Biolase Raises USD12 Million in Private Placement of Shares 29
Biolase Completes Private Placement Of Common Stock For USD 5 Million 30
Biolase Technology Files Registration Statement For Public Offering Of Securities For Up To USD 12.5 Million 31
Biolase Completes Private Placement Of Shares For USD 5 Million 32
Biolase Decreases Size Of Public Offering Of Securities For USD 5 Million 33
Asset Transactions 34
Biolase Sells 159 Waterlase MD Turbo Laser Systems 34
Biolase Inc-Key Competitors 35
Biolase Inc-Key Employees 36
Biolase Inc-Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Financial Announcements 38
May 02, 2018: BIOLASE Announces 2018 First Quarter Results 38
Nov 01, 2017: BIOLASE Reports 2017 Third Quarter and Nine-Month Results 40
Aug 07, 2017: BIOLASE Reports 2017 Second Quarter and Six-Month Results 42
May 03, 2017: BIOLASE Reports 2017 First Quarter Results 44
Mar 08, 2017: BIOLASE Reports 2016 Full Year and Fourth Quarter Results 46
Corporate Communications 48
Aug 08, 2018: BIOLASE names Todd A. Norbe President, Chief Executive Officer 48
Jun 19, 2018: BIOLASE Names Todd A. Norbe And Jess Roper As Board Directors 49
Apr 11, 2018: BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options 50
Apr 04, 2018: BIOLASE Names Garrett Sato To Board Of Directors 51
Mar 07, 2018: BIOLASE Secures USD 6 Million Revolving Line Of Credit 52
Oct 31, 2017: BIOLASE Appoints Richard B. Lanman to Board of Directors 53
Oct 02, 2017: BIOLASE Names John Beaver Senior Vice President, Chief Financial Officer 54
Sep 05, 2017: BIOLASE Names Jonathan T. Lord Chairman of the Board 55
May 05, 2017: BIOLASE Announces Management Change 56
Mar 13, 2017: BIOLASE Names James D. Surek Vice President Sales, Americas 57
Mar 01, 2017: BIOLASE Names Mark J. Nelson Chief Financial Officer 58
Jan 09, 2017: BIOLASE Announces Management Change 59
Legal and Regulatory 60
Jan 25, 2018: BIOLASE Rejects Frivolous, Abusive Patent Litigation 60
Jan 24, 2018: CAO Group Protects Its Diode Laser Patent Rights From Infringement By Biolase 61
Government and Public Interest 62
Mar 28, 2018: BIOLASE Announces Growing Awareness of Dental Lasers Among Pediatric Dentists, Demonstrating Shift Toward Pain-Free Dentistry 62
Other Significant Developments 63
Sep 12, 2018: BIOLASE Expands Its Initiative to Increase Dental Laser Awareness to Dallas-Fort Worth Area 63
May 09, 2018: BIOLASE and Los Angeles Chargers Partner to Bring Advanced Dental Care to Children in Underserved Communities in Southern California 64
Feb 15, 2018: BIOLASE Announces Initiatives to Increase Dental Laser Awareness and Education in Southern California 65
Appendix 66
Methodology 66
About GlobalData 66
Contact Us 66
Disclaimer 66
List of Figure
List of Figures
Biolase Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biolase Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biolase Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List of Table
List of Tables
Biolase Inc, Medical Equipment, Key Facts, 2017 2
Biolase Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Biolase Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Biolase Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Biolase Inc, Deals By Market, 2012 to YTD 2018 9
Biolase Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
BIOLASE Technology Acquires 180 Waterlase MD Turbo Laser Systems From Henry Schein 12
Biolase Enters Into Licensing Agreement With Valem 13
Biolase Enters into Research Agreement with McGuire Institute 14
Biolase Enters into Agreement with IPG Photonics 15
Biolase Enters Into Distribution Agreement With Stratasys 16
Biolase To Enter Into Co-Development Agreement With Auris Surgical Robotics 17
Biolase Enters Into Co-Marketing Agreement With Sun Dental Labs For TRIOS 18
Biolase Enters Into Distribution Agreement With 3Shape For TRIOS 19
BIOLASE Enters Into Co-Marketing Agreement With Cefla Dental 20
Biolase Plans to Raise Funds through Public Offering of Shares 21
Biolase Raises USD12 Million in Rights offering of Shares 22
Biolase Plans to Raise up to USD10 Million in Public Offering of Shares 23
Biolase Raises USD10 Million in Private Placement of Series D Preferred Stock 24
Biolase Raises USD10 Million in Private Placement of Preferred Stock 26
Biolase Raises USD35 Million in Private Placement of Shares 28
Biolase Raises USD12 Million in Private Placement of Shares 29
Biolase Completes Private Placement Of Common Stock For USD 5 Million 30
Biolase Technology Files Registration Statement For Public Offering Of Securities For Up To USD 12.5 Million 31
Biolase Completes Private Placement Of Shares For USD 5 Million 32
Biolase Decreases Size Of Public Offering Of Securities For USD 5 Million 33
Biolase Sells 159 Waterlase MD Turbo Laser Systems 34
Biolase Inc, Key Competitors 35
Biolase Inc, Key Employees 36
Biolase Inc, Subsidiaries 37
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.